Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Cerebral Edema l: Introduction01:19

Cerebral Edema l: Introduction

Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Renal hemodynamics underlie hepatorenal physiology in bile duct-ligated rats.

Clinical science (London, England : 1979)·2026
Same author

Factors affecting cognitive status in patients with intracranial atherosclerosis after surgical revascularization: a post hoc analysis of the ERSIAS-PC phase II trial.

Journal of neurosurgery·2026
Same author

Guidelines in Action: Cognitive Outcomes and Blood Pressure Control.

Stroke·2026
Same author

Guidelines in Action: Blood Pressure Management in the Setting of an Acute Intracerebral Hemorrhage.

Stroke·2026
Same author

Editorial: New insights on vascular and metabolic diabetic complications.

Frontiers in physiology·2026
Same author

Renoprotective approaches against anthracycline nephrotoxicity.

Biochemical pharmacology·2026
Same journal

Increased Insulin Resistance and Hyperglycemia in Long COVID: A Systematic Review and Meta-Analysis.

Expert reviews in molecular medicine·2026
Same journal

Harnessing the Vaginal Microbiome: A New Frontier in the Prevention of Sexually Transmitted Infections.

Expert reviews in molecular medicine·2026
Same journal

Beyond the stomach: Exploring the role of <i>Helicobacter pylori</i> in pushing precancerous lesions to colorectal cancer and the therapeutic potential of probiotics.

Expert reviews in molecular medicine·2026
Same journal

Microchimerism: The Hidden Cellular Dialogue Between Mother and Fetal That Shapes Lifelong Immunity.

Expert reviews in molecular medicine·2026
Same journal

Advances in m6A Modification in Pregnancy-Related Disorders and Female Reproductive Endocrine Diseases.

Expert reviews in molecular medicine·2026
Same journal

Dysregulation of the urea cycle - potential targets for treatment and diagnosis in prostate cancer.

Expert reviews in molecular medicine·2026
See all related articles

Related Experiment Video

Updated: Jun 4, 2026

Evaluation of Vascular Control Mechanisms Utilizing Video Microscopy of Isolated Resistance Arteries of Rats
10:28

Evaluation of Vascular Control Mechanisms Utilizing Video Microscopy of Isolated Resistance Arteries of Rats

Published on: December 5, 2017

Cytochrome P450 eicosanoids and cerebral vascular function.

John D Imig1, Alexis N Simpkins, Marija Renic

  • 1Department of Pharmacology & Toxicology, Medical College of Wisconsin, Milwaukee, WI 53226, USA. jdimig@mcw.edu

Expert Reviews in Molecular Medicine
|March 2, 2011
PubMed
Summary
This summary is machine-generated.

Cytochrome P450 (CYP) eicosanoids, 20-hydroxyeicosatetraenoic acid (20-HETE) and epoxyeicosatrienoic acids (EETs), regulate cerebral blood flow. Inhibiting 20-HETE or soluble epoxide hydrolase (sEH) reduces stroke damage.

More Related Videos

Paired Cisterna Magna Nanoinjection and Laser Speckle Contrast Imaging Assay to Study Cerebral Blood Flow Regulation In Vivo
06:24

Paired Cisterna Magna Nanoinjection and Laser Speckle Contrast Imaging Assay to Study Cerebral Blood Flow Regulation In Vivo

Published on: July 8, 2025

Evaluation of Bioenergetic Function in Cerebral Vascular Endothelial Cells
06:15

Evaluation of Bioenergetic Function in Cerebral Vascular Endothelial Cells

Published on: November 19, 2016

Related Experiment Videos

Last Updated: Jun 4, 2026

Evaluation of Vascular Control Mechanisms Utilizing Video Microscopy of Isolated Resistance Arteries of Rats
10:28

Evaluation of Vascular Control Mechanisms Utilizing Video Microscopy of Isolated Resistance Arteries of Rats

Published on: December 5, 2017

Paired Cisterna Magna Nanoinjection and Laser Speckle Contrast Imaging Assay to Study Cerebral Blood Flow Regulation In Vivo
06:24

Paired Cisterna Magna Nanoinjection and Laser Speckle Contrast Imaging Assay to Study Cerebral Blood Flow Regulation In Vivo

Published on: July 8, 2025

Evaluation of Bioenergetic Function in Cerebral Vascular Endothelial Cells
06:15

Evaluation of Bioenergetic Function in Cerebral Vascular Endothelial Cells

Published on: November 19, 2016

Area of Science:

  • Biochemistry
  • Vascular Biology
  • Neuroscience

Background:

  • Eicosanoids 20-hydroxyeicosatetraenoic acid (20-HETE) and epoxyeicosatrienoic acids (EETs) are derived from arachidonic acid metabolism by cytochrome P450 (CYP) enzymes.
  • These compounds play critical roles in regulating organ blood flow, including in the brain.

Purpose of the Study:

  • To investigate the mechanisms by which CYP eicosanoids regulate cerebral vascular function.
  • To explore the therapeutic potential of targeting 20-HETE and soluble epoxide hydrolase (sEH) for cerebral vascular diseases.

Main Methods:

  • Examining the generation and actions of 20-HETE and EETs in brain cells and cerebral blood vessels.
  • Investigating the role of CYP eicosanoids in cerebral blood flow autoregulation and neurovascular coupling.
  • Evaluating the effects of inhibiting 20-HETE or sEH in models of cerebral ischemia.

Main Results:

  • 20-HETE and EETs are significant contributors to cerebral blood flow regulation and neurovascular coupling.
  • Inhibition of 20-HETE or sEH demonstrably decreases cerebral damage following stroke.
  • These interventions improve cerebral vascular structure and function, while protecting neurons from death.

Conclusions:

  • CYP eicosanoids are crucial regulators of cerebral vascular function.
  • Targeting 20-HETE or sEH represents a promising therapeutic strategy for stroke and other neurological disorders.